Biblio

Export 538 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Keyword is N  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
D. A. Nation, Tan, A., Dutt, S., McIntosh, E. C., Yew, B., Ho, J. K., Blanken, A. E., Jang, J. Yun, Rodgers, K. E., and Gaubert, A., Circulating Progenitor Cells Correlate with Memory, Posterior Cortical Thickness, and Hippocampal Perfusion., J Alzheimers Dis, vol. 61, no. 1, pp. 91-101, 2018.
L. Wang, Qiao, Y., Zhang, H., Zhang, Y., Hua, J., Jin, S., and Liu, G., Circulating Vitamin D Levels and Alzheimer's Disease: A Mendelian Randomization Study in the IGAP and UK Biobank., J Alzheimers Dis, vol. 73, no. 2, pp. 609-618, 2020.
V. Bonet-Costa, Herranz-Pérez, V., Blanco-Gandía, M. C., Mas-Bargues, C., Inglés, M., Garcia-Tarraga, P., Rodriguez-Arias, M., Miñarro, J., Borras, C., Garcia-Verdugo, J. Manuel, and Viña, J., Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 3, pp. 701-11, 2016.
V. Bonet-Costa, Herranz-Pérez, V., Blanco-Gandía, M. C., Mas-Bargues, C., Inglés, M., Garcia-Tarraga, P., Rodriguez-Arias, M., Miñarro, J., Borras, C., Garcia-Verdugo, J. Manuel, and Viña, J., Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 3, pp. 701-11, 2016.
S. M. Rao, Galioto, R., Sokolowski, M., Pierce, M., Penn, L., Sturtevant, A., Skugor, B., Anstead, B., Leverenz, J. B., Schindler, D., Blum, D., Alberts, J. L., and Posk, L., Cleveland Clinic Cognitive Battery (C3B): Normative, Reliability, and Validation Studies of a Self-Administered Computerized Tool for Screening Cognitive Dysfunction in Primary Care., J Alzheimers Dis, vol. 92, no. 3, pp. 1051-1066, 2023.
T. Särkämö, Laitinen, S., Numminen, A., Kurki, M., Johnson, J. K., and Rantanen, P., Clinical and Demographic Factors Associated with the Cognitive and Emotional Efficacy of Regular Musical Activities in Dementia., J Alzheimers Dis, vol. 49, no. 3, pp. 767-81, 2016.
D. Andriuta, Si-Ahmed, C., Roussel, M., Constans, J. - M., Makki, M., Aarabi, A., Basille, D., Andrejak, C., and Godefroy, O., Clinical and Imaging Determinants of Neurocognitive Disorders in Post-Acute COVID-19 Patients with Cognitive Complaints., J Alzheimers Dis, vol. 87, no. 3, pp. 1239-1250, 2022.
D. Andriuta, Si-Ahmed, C., Roussel, M., Constans, J. - M., Makki, M., Aarabi, A., Basille, D., Andrejak, C., and Godefroy, O., Clinical and Imaging Determinants of Neurocognitive Disorders in Post-Acute COVID-19 Patients with Cognitive Complaints., J Alzheimers Dis, vol. 87, no. 3, pp. 1239-1250, 2022.
Y. - L. Chang, Yen, Y. - S., Chen, T. - F., Yan, S. - H., and Tseng, W. - Y. Isaac, Clinical Dementia Rating Scale Detects White Matter Changes in Older Adults at Risk for Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 2, pp. 411-23, 2016.
Q. Lin Chan, Xu, X., Shaik, M. Amin, Chong, S. Shih Tsze, Hui, R. Jor Yeong, Chen, C. Li- Hsian, and Dong, Y. H., Clinical utility of the informant AD8 as a dementia case finding instrument in primary healthcare., J Alzheimers Dis, vol. 49, no. 1, pp. 121-7, 2016.
M. Grassi, Perna, G., Caldirola, D., Schruers, K., Duara, R., and Loewenstein, D. A., A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer's Disease Conversion in Individuals with Mild and Premild Cognitive Impairment., J Alzheimers Dis, vol. 61, no. 4, pp. 1555-1573, 2018.
C. Rosario Ilardi, Menichelli, A., Michelutti, M., Cattaruzza, T., Federico, G., Salvatore, M., Iavarone, A., and Manganotti, P., On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer's Disease., J Alzheimers Dis, vol. 101, no. 1, pp. 293-308, 2024.
R. Thangavel, Bhagavan, S. M., Ramaswamy, S. Beladakere, Surpur, S., Govindarajan, R., Kempuraj, D., Zaheer, S., Raikwar, S., Ahmed, M. E., Selvakumar, G. Pushpavath, Iyer, S. S., and Zaheer, A., Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain., J Alzheimers Dis, vol. 61, no. 2, pp. 553-560, 2018.
C. Rattanabannakit, Risacher, S. L., Gao, S., Lane, K. A., Brown, S. A., McDonald, B. C., Unverzagt, F. W., Apostolova, L. G., Saykin, A. J., and Farlow, M. R., The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests., J Alzheimers Dis, vol. 51, no. 4, pp. 1145-55, 2016.
C. Costa, Vecchio, F., Romoli, M., Miraglia, F., Cesarini, E. Nardi, Alù, F., Calabresi, P., and Rossini, P. Maria, Cognitive Decline Risk Stratification in People with Late-Onset Epilepsy of Unknown Etiology: An Electroencephalographic Connectivity and Graph Theory Pilot Study., J Alzheimers Dis, vol. 88, no. 3, pp. 893-901, 2022.
A. Tsiakiri, Vlotinou, P., Terzoudi, A., Heliopoulos, I., and Vadikolias, K., Cognitive, Functional, and Emotional Changes During the COVID-19 Pandemic in Greek Patients with Neurocognitive Disorders., J Alzheimers Dis, vol. 88, no. 2, pp. 537-547, 2022.
A. Tsiakiri, Vlotinou, P., Terzoudi, A., Heliopoulos, I., and Vadikolias, K., Cognitive, Functional, and Emotional Changes During the COVID-19 Pandemic in Greek Patients with Neurocognitive Disorders., J Alzheimers Dis, vol. 88, no. 2, pp. 537-547, 2022.
L. Xiong, Davidsdottir, S., Reijmer, Y. D., Shoamanesh, A., Roongpiboonsopit, D., Thanprasertsuk, S., Martinez-Ramirez, S., Charidimou, A., Ayres, A. M., Fotiadis, P., Gurol, E., Blacker, D. L., Greenberg, S. M., and Viswanathan, A., Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit., J Alzheimers Dis, vol. 52, no. 1, pp. 171-8, 2016.
M. Balietti, Giuli, C., Fattoretti, P., Fabbietti, P., Postacchini, D., and Conti, F., Cognitive Stimulation Modulates Platelet Total Phospholipases A2 Activity in Subjects with Mild Cognitive Impairment., J Alzheimers Dis, vol. 50, no. 4, pp. 957-62, 2016.
C. E. Gleason, Norton, D., Anderson, E. D., Wahoske, M., Washington, D. T., Umucu, E., Koscik, R. L., N Dowling, M., Johnson, S. C., Carlsson, C. M., and Asthana, S., Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker., J Alzheimers Dis, vol. 61, no. 1, pp. 79-89, 2018.
K. Hensley and Kursula, P., Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau., J Alzheimers Dis, vol. 53, no. 1, pp. 1-14, 2016.
M. A. Gregory, Silva, N. C. Boa Sort, Gill, D. P., McGowan, C. L., Liu-Ambrose, T., J Shoemaker, K., Hachinski, V., Holmes, J., and Petrella, R. J., Combined Dual-Task Gait Training and Aerobic Exercise to Improve Cognition, Mobility, and Vascular Health in Community-Dwelling Older Adults at Risk for Future Cognitive Decline1., J Alzheimers Dis, vol. 57, no. 3, pp. 747-763, 2017.
A. Dodich, Cerami, C., Cappa, S. F., Marcone, A., Golzi, V., Zamboni, M., Giusti, M. Cristina, and Iannaccone, S., Combined Socio-Behavioral Evaluation Improves the Differential Diagnosis Between the Behavioral Variant of Frontotemporal Dementia and Alzheimer's Disease: In Search of Neuropsychological Markers., J Alzheimers Dis, vol. 61, no. 2, pp. 761-772, 2018.
Y. Yamada, Shinkawa, K., Kobayashi, M., Caggiano, V., Nemoto, M., Nemoto, K., and Arai, T., Combining Multimodal Behavioral Data of Gait, Speech, and Drawing for Classification of Alzheimer's Disease and Mild Cognitive Impairment., J Alzheimers Dis, vol. 84, no. 1, pp. 315-327, 2021.
L. Fernández-Romero, Morello-García, F., Laforce, R., Delgado-Alonso, C., Delgado-Álvarez, A., Gil-Moreno, M. José, Lavoie, M., Matías-Guiu, J., Cuetos, F., and Matías-Guiu, J. A., Comparative accuracy of Mini-Linguistic State Examination, Addenbrooke's Cognitive Examination, and Depistage Cognitif de Quebec for the diagnosis of primary progressive aphasia., J Alzheimers Dis, vol. 102, no. 1, pp. 67-76, 2024.

Pages